Related Experiment Video

Updated: May 31, 2026

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on: July 12, 2018

Cambogin is preferentially cytotoxic to cells expressing PDGFR

Ze Tian1, Jie Shen, Fengfei Wang

  • 1Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China. ze_tian@dfci.harvard.edu

Plos One
|June 30, 2011
PubMed

Insights

Cambogin effectively targets medulloblastoma (MB) cells by inducing cell cycle arrest and apoptosis. This compound inhibits Platelet-Derived Growth Factor Receptor (PDGFR) signaling, offering a potential new therapeutic strategy for MB treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Medulloblastoma (MB) is the most common pediatric brain tumor, posing significant therapeutic challenges.
  • Platelet-Derived Growth Factor Receptors (PDGFRs) are implicated in various human cancers, including MB.
  • Targeting PDGFR signaling represents a promising avenue for novel MB therapeutics.

Purpose of the Study:

  • To investigate the cytotoxic effects and underlying mechanisms of cambogin in Daoy MB cells.
  • To determine if cambogin inhibits PDGFR signaling pathways.
  • To evaluate cambogin as a potential targeted therapy for MB.

Main Methods:

  • Cytotoxicity assays were performed on Daoy MB cells treated with cambogin.
  • Cell cycle progression and apoptosis were analyzed using flow cytometry and Western blotting.
  • PDGFR signaling inhibition was assessed in Daoy MB and mouse embryo fibroblast (MEF) cell lines.

Main Results:

  • Cambogin induced significant S phase cell cycle arrest and apoptosis in Daoy MB cells.
  • Apoptosis was mediated by the downregulation of cyclin A and E, and activation of caspases.
  • Cambogin demonstrated inhibition of PDGFR signaling in both MB and MEF cell lines, suggesting preferential cytotoxicity to PDGFR-expressing cells.

Conclusions:

  • Cambogin exhibits potent anti-cancer activity against medulloblastoma cells.
  • The mechanism involves cell cycle arrest, apoptosis induction, and PDGFR signaling inhibition.
  • Cambogin represents a promising novel therapeutic agent for targeting PDGFR signaling in MB treatment.

More Related Videos

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease06:25

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on: March 29, 2024

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...